Evidence map›Paper›PMID 27620721›Full record

ArticleInfection and immunity2016

Toll-Like Receptor 2 Agonist Pam3CSK4 Alleviates the Pathology of Leptospirosis in Hamster.

Wenlong Zhang, Naisheng Zhang, Xufeng Xie, Jian Guo, Xuemin Jin, Feng Xue, Zhuang Ding, Yongguo Cao

Abstract read
In one paragraph

Article in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Trends and advances inFrontiers in microbiology · 2024
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Subversion of the immune response of human pathogenic spirochetes.Journal of clinical laboratory analysis · 2022
    Review
  7. Article
  8. IL-10 Deficiency Protects Hamsters fromInfection and immunity · 2022
    Article
  9. Article
  10. Review
  11. Phagocyte Escape ofFrontiers in immunology · 2020
    Review
  12. Review
  13. Article
  14. Increased inflammation with crudeEmerging microbes & infections · 2020
    Article
  15. The preventable efficacy of β-glucan against leptospirosis.PLoS neglected tropical diseases · 2019
    Article
  16. Observational
  17. Article
  18. Article
  19. Spirochetal Lipoproteins and Immune Evasion.Frontiers in immunology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenlong ZhangDepartment of Clinical Science, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, People's Republic of China.
Naisheng ZhangDepartment of Clinical Science, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, People's Republic of China.
Xufeng XieDepartment of Clinical Science, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, People's Republic of China.
Jian GuoDepartment of Clinical Science, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, People's Republic of China.
Xuemin JinDepartment of Clinical Science, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, People's Republic of China.
Feng XueBeijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Zhuang DingDepartment of Infectious Disease, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, People's Republic of China dingzhuang@jlu.edu.cn ygcao82@jlu.edu.cn.
Yongguo CaoDepartment of Clinical Science, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, People's Republic of China dingzhuang@jlu.edu.cn ygcao82@jlu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptospirosis, caused by pathogenic spirochetes, is a zoonotic disease of global importance. The detailed pathogenesis of leptospirosis is still unclear, which limits the ideal treatment of leptospirosis. In this study, we analyzed the expression of Toll-like receptor 2 (TLR2) and TLR4 in target organs of both resistant mice and susceptible hamsters after Leptospira interrogans serovar Autumnalis infection. TLR2 but not TLR4 transcripts in mouse organs contrasted with delayed induction and overexpression in hamster organs. Coinjection of leptospires and the TLR2 agonist Pam3CSK4 into hamsters improved their survival rate, alleviated tissue injury, and decreased the abundance of leptospires in target organs. The production of interleukin-10 (IL-10) from tissues was enhanced in hamsters of the group coinjected with leptospires and Pam3CSK4 compared with the leptospira-injected group. Similarly, IL-10 levels in TLR2-deficient mice were lower than those in wild-type mice. A high ratio of IL-10/tumor necrosis factor alpha (TNF-α) levels was found in both infected wild-type mice and hamsters coinjected with leptospires and Pam3CSK4. Moreover, TLR2-dependent IL-10 expression was detected in peritoneal macrophages after leptospira infection. Our data demonstrate that coinjection of leptospires and Pam3CSK4 alleviates the pathology of leptospirosis in hamsters; this effect may result from the enhanced expression of TLR2-dependent IL-10.

Indexed as

AnimalsCricetinaeFemaleGene Expression RegulationInterleukin-10Leptospira interrogansLeptospirosisLipopeptidesMiceMice, Inbred BALB CRNA, MessengerToll-Like Receptor 2Toll-Like Receptor 4Interleukin-10LipopeptidesPam(3)CSK(4) peptideRNA, MessengerToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID27620721
PMCPMC5116713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.